Investigation of miltefosine-model membranes interactions at the molecular level for two different PS levels modeling cancer cells
dc.authorid | Bilge, Duygu Melek/0000-0002-5229-7972 | |
dc.contributor.author | Cetinel, Zueleyha Ozcelik | |
dc.contributor.author | Bilge, Duygu | |
dc.date.accessioned | 2024-08-31T07:48:24Z | |
dc.date.available | 2024-08-31T07:48:24Z | |
dc.date.issued | 2024 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Miltefosine (MLT) is a broad-spectrum drug included in the alkylphospholipids (APL) used against leishmania and various types of cancer. The most crucial feature of APLs is that they are thought to only kill cancerous cells without harming normal cells. However, the molecular mechanism of action of APLs is not completely understood. The increase in the phosphatidylserine (PS) ratio is a marker showing the stage of cancer and even metastasis. The goal of this research was to investigate the molecular effects of miltefosine at the molecular level in different PS ratios. The effects of MLT on membrane phase transition, membrane orders, and dynamics were studied using DPPC/DPPS (3:1) and DPPC/DPPS (1:1) multilayer (MLV) vesicles mimicking DPPS ratio variation, Differential Scanning Calorimetry (DSC), and Fourier Transform Infrared spectroscopy (FTIR). Our findings indicate that miltefosine is evidence at the molecular level that it is directed towards the tumor cell and that the drug's effect increases with the increase of anionic lipids in the membrane depending on the stage of cancer. | en_US |
dc.description.sponsorship | Ege University; [FDK-2019-20901] | en_US |
dc.description.sponsorship | We would like to thank Ege University Scientific Research Projects Coordination for their support of this study. (The project ID is FDK-2019-20901). | en_US |
dc.identifier.doi | 10.1007/s10863-024-10025-y | |
dc.identifier.endpage | 473 | en_US |
dc.identifier.issn | 0145-479X | |
dc.identifier.issn | 1573-6881 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 38833041 | en_US |
dc.identifier.scopus | 2-s2.0-85195219573 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 461 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s10863-024-10025-y | |
dc.identifier.uri | https://hdl.handle.net/11454/104774 | |
dc.identifier.volume | 56 | en_US |
dc.identifier.wos | WOS:001239260700002 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer/Plenum Publishers | en_US |
dc.relation.ispartof | Journal of Bioenergetics and Biomembranes | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | 20240831_U | en_US |
dc.subject | Fourier Transformation Infrared Spectroscopy | en_US |
dc.subject | Differential Scanning Calorimetry | en_US |
dc.subject | Miltefosine | en_US |
dc.subject | Dipalmitoyl Phosphatidylserine Level | en_US |
dc.subject | Cancer | en_US |
dc.title | Investigation of miltefosine-model membranes interactions at the molecular level for two different PS levels modeling cancer cells | en_US |
dc.type | Article | en_US |